Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Viral kinetics in hepatitis C virus: special patient populations.

Seminars in liver disease - 1 Jan 2003

Layden-Almer Jennifer E, Layden Thomas J

Abstract excerpt

The evolution in therapy for chronic hepatitis C virus (HCV) infection to the more recent use of peginterferons in combination with ribavirin has dramatically increased the sustained virological response (SVR) rates versus standard interferon/ ribavirin combination therapy. However, although pegi...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Black or African American
Share to Drug Carriers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepacivirus

Share to Hepatitis C, Chronic

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Polyethylene Glycols

Source

Identifiers

PMID: 12934166
DOI: 10.1055/s-2003-41632

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-12934166-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Viral kinetics in hepatitis C virus: special patient populations.PMID 12934166Read ↗

Treatment Considerations for Unique Patient Populations With HCV Genotype 1 Infection.Semantic proximity Read ↗

Implications of rapid virological response in hepatitis C therapy in the US veteran population.Semantic proximity Read ↗

Customizing treatment to patient populations.Semantic proximity Read ↗

Twice-weekly pegylated interferon-α-2a and ribavirin results in superior viral kinetics in HIV/hepatitis C virus co-infected patients compared to standard therapy.Semantic proximity Read ↗

A perspective on modelling hepatitis C virus infectionSemantic proximity Read ↗

Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States.Semantic proximity Read ↗

Pegylated interferon fractal pharmacokinetics: individualized dosing for hepatitis C virus infection.Semantic proximity Read ↗

Early changes in hepatitis C virus (HCV) levels in response to peginterferon and ribavirin treatment in patients with chronic HCV genotype 1 infection.Semantic proximity Read ↗

Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients.Semantic proximity Read ↗

Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virus.Semantic proximity Read ↗

Peginterferon pharmacokinetics in African American and Caucasian American patients with hepatitis C virus genotype 1 infection.Semantic proximity Read ↗

Viral dynamics and response differences in HCV-infected African American and white patients treated with IFN and ribavirin.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.